The development of ultrasensitive ELISA or particle-enhanced techniques has allowed the detection limits of CRP concentration (hs-CRP) to be less than 0.3 mg/L [33, 34] Unlike CRP, hs-CRP is typically recognized as an indicator of upcoming stroke, peripheral vascular disease and acute myocardial infarction. Here, CRP is linked to stroke disorder.